- 4-Week # shares sold: 6,000
- 12-Week # shares sold: 17,883
- 24-Week # shares sold: 20,883
DaVita (DVA) today announced it will suspend support for applications to the American Kidney Fund by Medicaid patients who are seeking additional coverage under the Affordable Care Act.
DaVita's (DVA) stock rating was reduced to 'neutral' from 'buy' at BofA/Merrill on Tuesday.